A phase II, randomized, open-label, dose-finding study of TAS-108, a novel steroidal antiestrogen, administered orally in postmenopausal women with advanced or metastatic breast cancer.

2009 ◽  
Author(s):  
H Iwata ◽  
H Inaji ◽  
T Nakayama ◽  
N Yamamoto ◽  
S Noguchi ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Postmenopausal Women ◽  
Phase Ii ◽  
Metastatic Breast ◽  
Dose Finding ◽  
Open Label ◽  
Finding Study ◽  
Label Dose ◽  
Dose Finding Study

High-Dose Epirubicin + Cyclophosphamide (HD-EC) in Metastatic Breast Cancer: A Dose-Finding Study

1988 ◽  
Vol 11 (6) ◽  
pp. 287-288 ◽  
Author(s):  
G.A. Nagel ◽  
J.-H. Beyer ◽  
W. Holtkamp ◽  
D. Emrich ◽  
M. Kneba ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Metastatic Breast ◽  
Dose Finding ◽  
High Dose ◽  
Finding Study ◽  
Dose Finding Study

scholarly journals Dose-finding study of docetaxel and doxorubicin in first-line treatment of patients with metastatic breast cancer

1999 ◽  
Vol 10 (5) ◽  
pp. 553-560 ◽  
Author(s):  
J.L. Misset ◽  
V. Dieras ◽  
G. Gruia ◽  
H. Bourgeois ◽  
E. Cvitkovic ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Metastatic Breast ◽  
Dose Finding ◽  
Line Treatment ◽  
First Line ◽  
Finding Study ◽  
Dose Finding Study ◽  
First Line Treatment

scholarly journals Correction to: Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study

Breast Cancer ◽  
2017 ◽  
Vol 25 (1) ◽  
pp. 126-126
Author(s):  
Masaya Hattori ◽  
Hiroshi Ishiguro ◽  
Norikazu Masuda ◽  
Akiyo Yoshimura ◽  
Shoichiro Ohtani ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase I ◽  
Metastatic Breast ◽  
Dose Finding ◽  
Finding Study ◽  
Dose Finding Study
Sign in / Sign up

Export Citation Format

Share Document